Weizmann Institute-Born Cell Therapy Technology In Clinical Trials for ALS Patients
TrialSite News,
Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S.
Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S.
ALS News Today brought you daily coverage of important discoveries, treatment developments, clinical trials, and other events…
Izrael M, Slutsky SG, Admoni T, Cohen L, Granit A, Hasson A, Itskovitz-Eldor J, Krush Paker L, Kuperstein G, Lavon N, Yehezkel…
SOURCE Kadimastem The article describes the comprehensive scientific research of the company's flagship product, AstroRx®…